Art

J-GLOBAL ID：201702240847694605   Reference number：17A1692748

Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014-2015

日本の手術部位感染症から分離された病原体の抗菌剤感受性:2010年および2014-2015年に実施された全国的サーベイランス研究のデータの比較

Author (40)： Takesue Yoshio (The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan) ,  Takesue Yoshio (Hyogo College of Medicine, Hyogo, Japan) ,  Kusachi Shinya (The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan) ,  Kusachi Shinya (Department of Surgery, Toho University Medical Center Ohashi, Tokyo, Japan) ,  Mikamo Hiroshige (The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan) ,  Mikamo Hiroshige (Aichi Medical University Hospital, Aichi, Japan) ,  Sato Junko (The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan) ,  Watanabe Akira (The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan) ,  Kiyota Hiroshi (The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan) ,  Iwata Satoshi (The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan) ,  Kaku Mitsuo (The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan) ,  Hanaki Hideaki (Kitasato University Institute, Tokyo, Japan) ,  Sumiyama Yoshinobu (Japan Society for Surgical Infection, Tokyo, Japan) ,  Sumiyama Yoshinobu (Department of Surgery, Toho University Medical Center Ohashi, Tokyo, Japan) ,  Kitagawa Yuko (Japan Society for Surgical Infection, Tokyo, Japan) ,  Kitagawa Yuko (Department of Surgery, Keio University School of Medicine, Tokyo, Japan) ,  Mizuguchi Toru (Department of Surgery, Surgical Oncology & Science Sapporo Medical University, Hokkaido, Japan) ,  Ambo Yoshiyasu (Department of Surgery, Teine Keijinkai Hospital, Hokkaido, Japan) ,  Konosu Masafumi (Iwate Medical University, Iwate, Japan) ,  Ishibashi Keiichiro (Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan) ,  Matsuda Akihisa (Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan) ,  Hase Kazuo (National Defense Medical College, Saitama, Japan) ,  Harihara Yasushi (NTT Medical Center Tokyo, Tokyo, Japan) ,  Okabayashi Koji (Department of Surgery, Keio University School of Medicine, Tokyo, Japan) ,  Seki Shiko (Department of Surgery, National Hospital Organization Tokyo Medical Center, Tokyo, Japan) ,  Hara Takuo (Department of Surgery, Kouseiren Takaoka Hospital, Toyama, Japan) ,  Matsui Koshi (Department of Surgery and Science, University of Toyama, Toyama, Japan) ,  Matsuo Yoichi (Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan) ,  Kobayashi Minako (Department of Innovative Surgery, Mie University Graduate School of Medicine, Mie, Japan) ,  Kubo Shoji (Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan) ,  Uchiyama Kazuhisa (Osaka Medical College, Department of General and Gastroenterological Surgery, Osaka, Japan) ,  Shimizu Junzo (Department of Surgery, Osaka Rosai Hospital, Osaka, Japan) ,  Kawabata Ryohei (Saki City Medical Center, Osaka, Japan) ,  Ohge Hiroki (Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan) ,  Akagi Shinji (Department of Surgery, Mazda Hospital, Mazda Motor Corporation, Hiroshima, Japan) ,  Oka Masaaki (Yamaguchi University, Yamaguchi, Japan) ,  Wakatsuki Toshiro (Tottori University Faculty of Medicine, Tottori, Japan) ,  Suzuki Katsunori (University of Occupational and Environmental Health, Fukuoka, Japan) ,  Okamoto Kohji (Department of Surgery, Gastroenterology and Hepatology Center, Kitakyushu City Yahata Hospital, Fukuoka, Japan) ,  Yanagihara Katsunori (Nagasaki University School of Medicine, Nagasaki, Japan)
Material： Journal of Infection and Chemotherapy  (J Infect Chemother)
Volume： 23  Issue： 6  Page： 339-348  Publication year： Jun. 2017 
JST Material Number： L2852A  ISSN： 1341-321X  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： *postoperative infection ,...
Semi thesaurus term： Methicillin Resistance ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1692748&from=J-GLOBAL&jstjournalNo=L2852A") }}

Author keywords (4)： Surgical site infections ,  Surveillance ,  Antibiotic susceptibility ,  Bacteroides fragilis group

JST classification (2)： Infectious diseases,parasitics diseases in general.  (GD01010H) ,  Clinical application of antibiotics acting on pathogenic organisms  (GX05030N)

Substance index (5)： piperacillin/Tazobactam ,  Vancomycin ,  Piperacillin ,  Flomoxef ,  Meropenem

Reference (41)：

• Sawa A, Morikane K, Harihara Y, Simizu J. Annual report of JHAIS SSI surveillance (No.17). Jpn J Infect Prev Control 2016;31:335-43 [in Japanese].
• Anthony T, Long J, Hynan LS, Sarosi Jr GA, Nwariaku F, Huth J, et al. Surgical complications exert a lasting effect on disease-specific health-related quality of life for patients with colorectal cancer. Surgery 2003;134:119-25.
• Astagneau P, Rioux C, Golliot F, Brucker G. INCISCO Network Study Group. Morbidity and mortality associated with surgical site infections: results from the 1997-1999 INCISO surveillance. J Hosp Infect 2001;48:267-74.
• Dimick JB, Chen SL, Taheri PA, Henderson WG, Khuri SF, Campbell Jr DA. Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg 2004;199:531-7.
• Kirkland KB, Briggs JP, Trivette S, Wilkinson WE, Sedon DJ. The impact of surgical-site infection in the 1990s: attribute mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20: 725-30.

Terms in the title (7)： 日本 ,  手術部位感染症 ,  病原体 ,  抗菌剤感受性 ,  実施 ,  サーベイランス ,  研究